IR
63
-3
NKE
42
3
UNH
34
-2
SE
63
6
LLY
82
-2
DAL
68
-2
RSG
48
4
BRK.B
45
3
IVZ
63
-3
DVN
42
3
M
46
-2
T
29
2
AXP
67
-4
EA
47
-3
FDX
72
-3
C
79
-2
KEY
72
-2
DTE
45
3
PLD
32
-3
ORLY
44
-3
IR
63
-3
NKE
42
3
UNH
34
-2
SE
63
6
LLY
82
-2
DAL
68
-2
RSG
48
4
BRK.B
45
3
IVZ
63
-3
DVN
42
3
M
46
-2
T
29
2
AXP
67
-4
EA
47
-3
FDX
72
-3
C
79
-2
KEY
72
-2
DTE
45
3
PLD
32
-3
ORLY
44
-3
Financhill
Back

Ono Pharmaceutical Co., Ltd. 10K Form

Buy
55

OPHLF
Ono Pharmaceutical Co., Ltd.

Last Price:
$12.87
Seasonality Move:
5.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OPHLF News And Ratings

See the #1 stock for the next 7 days that we like better than OPHLF

OPHLF Financial Statistics

Sales & Book Value

Annual Sales: $3.2B
Cash Flow: $339.9M
Price / Cash Flow: 11.82
Annual Sales: $11.62
Price / Book: 1.11

Profitability

EPS (TTM): 0.70090
Net Income (TTM): $329.5M
Gross Margin: $2.2B
Return on Equity: 6.13%
Return on Assets: 4.63%

Ono Pharmaceutical Co., Ltd. Earnings Forecast

Key Ono Pharmaceutical Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 45 years for OPHLF is 68.90%.
  • The Selling, General & Administrative Expenses for OPHLF have been equal to 25.81% of Gross Profit Margin.
  • The Research & Development expenses have been 30.78% of Revenue.
  • The Interest Expense is 3.26% of Operating Income.
  • The Net Earning history of OPHLF is 10.30% of Total Revenues.
  • Per Share Earnings over the last 45 years have been positive in 30 years.

Ono Pharmaceutical Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OPHLF
Website: ono-pharma.com/ja

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 2.99
Quick Ratio: 2.29

Price-to-Earnings

Trailing P/E Ratio: 18.44
Forward P/E Ratio: 0

OPHLF Technical Analysis vs Fundamental Analysis

Buy
55
Ono Pharmaceutical Co., Ltd. (OPHLF) is a Buy

Is Ono Pharmaceutical Co., Ltd. a Buy or a Sell?